Accelerate Cancer Vaccine Development in China via Fast Track
CK Life Sciences, a subsidiary of Li Ka Shing Group, announced plans to introduce its cancer vaccines to mainland China through a 'Fast Track' channel. This initiative aims to expedite the development of early-stage drugs, with clinical trials set to begin next year.